InvestorsHub Logo
Followers 13
Posts 940
Boards Moderated 0
Alias Born 08/27/2015

Re: Fasctrack post# 71028

Tuesday, 12/12/2023 11:02:45 AM

Tuesday, December 12, 2023 11:02:45 AM

Post# of 73046
Assuming the issue was uncovered in October and that's why it was delayed another 2-3 months? That would put it on a timeline to being finalized in January now. A big challenge with testing facilities is contamination. I have seen this happen with another medical product over the last year or so too. The issue knocked them back over a year with FDA protocols to get their product into the market. They're also on a January timeline now too.

Found this guide https://www.pharmaguideline.com/2012/02/guidelines-for-stability-study.html

It seems helpful. Vitastem currently has a shelf life for 2 years. My assumptions are they are siding on caution to make sure this is 100% ready to GTM in early 2024 to supply all the large volume orders in waiting that they announced in that previous press release.

Also, the tweets were signed by Dr Otiko. That's the first time I have ever seen that and he seems to be stepping up to the plate now. TBD but it seems VDRM is getting much closer to making some very big moves for the business.
Bullish
Bullish